← Eichor
Study identifier: NCT06820606 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparing Rezum and Urolift

Condition: Prostate Cancer  ·  Sponsor: Chinese University of Hong Kong

PhaseNA
Planned participants120
Who can joinMale, 50 Years to no upper limit
Healthy volunteersNo

About this study

This is a randomized controlled trial using a non-inferiority design with the subjects randomized 1:1 to either water vapour thermal treatment (REZUM) arm or prostatic urethral lift (UroLift) arm.

This description comes directly from the study's public registry record.

Talk to the study team

Peter Ka-Fung CHIU  ·  +852 3505 3933  ·  peterchiu@surgery.cuhk.edu.hk

Always discuss trial participation with your own doctor first.

Locations (1)

Prince of Wales Hospital, The Chinese University of Hong KongHong Kong, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06820606